Cargando…
Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells
Psoriasis is a common, chronic, inflammatory skin disease that affects 2%–4% of the global population. Recent studies have shown that increased oxidative stress (OS) and T-cell abnormalities are central to the pathogenesis of this disease. The resulting reactive oxygen species (ROS) induces prolifer...
Autores principales: | Lai, Rui, Xian, Dehai, Xiong, Xia, Yang, Lingyu, Song, Jing, Zhong, Jianqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748681/ https://www.ncbi.nlm.nih.gov/pubmed/29630472 http://dx.doi.org/10.1080/13510002.2018.1462027 |
Ejemplares similares
-
Proanthocyanidins against Oxidative Stress: From Molecular Mechanisms to Clinical Applications
por: Yang, Lingyu, et al.
Publicado: (2018) -
An Emerging Role of Proanthocyanidins on Psoriasis: Evidence from a Psoriasis-Like Mouse Model
por: Yang, Yang, et al.
Publicado: (2022) -
Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses
por: Xian, Dehai, et al.
Publicado: (2019) -
The protective effect of proanthocyanidins on the psoriasis-like cell models via PI3K/AKT and HO-1
por: Zhao, Yangmeng, et al.
Publicado: (2022) -
Proanthocyanidins as a Potential Novel Way for the Treatment of Hemangioma
por: Tang, Ran, et al.
Publicado: (2021)